Douglas T. Ross, Chief Scientific Officer at Oncocyte Corp (OCX), bought 15,000 shares at $1.40 ($21K) on 2022-03-25, disclosed to the SEC on 2022-03-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.